Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Kevin_Judice
|
| gptkbp:developedBy |
oral small molecule drugs
|
| gptkbp:focusesOn |
immunology
drug discovery inflammatory diseases small molecule therapeutics |
| gptkbp:formerName |
DiCE Therapeutics
|
| gptkbp:foundedYear |
2013
|
| gptkbp:founder |
Pehr Harbury
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
DiCE Molecules
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:specializesIn |
DNA-encoded chemical libraries
|
| gptkbp:stockSymbol |
gptkb:DICE
|
| gptkbp:website |
https://www.dicetherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Kevin_Judice
|
| gptkbp:bfsLayer |
8
|